Verve Therapeutics Inc.

In News

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - Eli Lilly

Eli Lilly - Jun 17, 2025

Weekly Recap: How institutional buying supports Verve Therapeutics Inc. stock - Dollar Strength & Real-Time Stock Price Movement Reports - mfd.ru

mfd.ru - Feb 14, 2026

Verve Therapeutics, Inc. (VERV): A Bull Case Theory - Yahoo Finance

Yahoo Finance - Jul 10, 2025

Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk - PR Newswire

PR Newswire - Jul 25, 2025

Lilly to Acquire Verve Therapeutics for Up to $1.3B - GEN - Genetic Engineering and Biotechnology News

GEN - Genetic Engineering and Biotechnology News - Jun 17, 2025

Eli Lilly to Acquire Verve Therapeutics to Advance One-Time Cardiovascular Treatments - CRISPR Medicine News

CRISPR Medicine News - Jun 17, 2025

Lilly to acquire Verve Therapeutics for $1.3 billion - C&EN

C&EN - Jun 18, 2025

Wilson Sonsini Advises Verve Therapeutics on IP Matters Related to Merger with Lilly - Wilson Sonsini

Wilson Sonsini - Jun 17, 2025

Why Verve Therapeutics Stock Is Skyrocketing Today - The Motley Fool

The Motley Fool - Jun 17, 2025

Lilly to acquire Verve in $1B bet on gene editing for heart disease - BioPharma Dive

BioPharma Dive - Jun 17, 2025

Lilly to Acquire Verve Therapeutics in $1.3B Deal Targeting One-Time Gene-Editing Treatments for Cardiovascular Disease - BioPharm International

BioPharm International - Jun 17, 2025

Eli Lilly to acquire gene-editing biotech company Verve Therapeutics for $1.3 billion. Here's why - MSN

MSN - Feb 13, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment